Macroaxis: Personalized Investing
Simple Personalized Investing

JNJ PFE NVS SNY Compulsion Advertising Diversified Assets Recent Drops 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for AZN

AstraZeneca performance

 
 Companies |  Insiders  | Dashboard  
     

AstraZeneca PLC

Stock@New York Stock Exchange 
United States USD
     
Use AstraZeneca PLC performance within your existing portfolios mixed with equities fromn New York Stock Exchange to enhance returns of your portfolios as well as to determine Stock diversification method that is right for you.  Build Portfolio
Investment horizon: 
  30 Days    Login   to change

Relative Risk vs. Return Landscape

If you would invest  5,155  in AstraZeneca PLC on April 25, 2013 and sell it today you would earn a total of  62.00  from holding AstraZeneca PLC or generate 1.2% return on investment over 30 days. AstraZeneca PLC is generating 0.09% of daily returns assuming volatility of 0.65% on return distribution over 30 days investment horizon. In other words, 8% of equities are less volatile than the company and above 95% of equities are expected to generate higher returns over the next 30 days.
Daily Expected Return (%)
 
Change Benchmark   Risk [Daily Volatility] (%)
Considering 30-days investment horizon, AstraZeneca PLC is expected to generate 2.11 times less return on investment than the market. In addition to that, the company is 1.1 times more volatile than its market benchmark. It trades about 0.14 of its total potential returns per unit of risk. The S&P 500 is currently generating roughly 0.32 per unit of volatility.

AstraZeneca Operating Margin

Based on recorded statements AstraZeneca PLC has Operating Margin of 32.53%. This is 221.34% lower than that of Healthcare sector, and 230.85% lower than that of Drug Manufacturers - Major industry, The Operating Margin for all stocks is 1008.66% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

AstraZeneca Return On Equity vs Return On Asset

AstraZeneca PLC is rated fourth in return on equity category among related companies. It is rated third in return on asset category among related companies reporting about  0.41  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AstraZeneca PLC is roughly  2.43 
AstraZeneca
Performance
7
Out Of
100
Over 30
Days
93% of all equities and portfolios perform better than AstraZeneca PLC. Compared with the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC are ranked lower than 7 (%) of all global equities and portfolios over the last 30 days.
Embed widgets for AstraZeneca
Financial widgets and gadgets
Live stock tickers for equities

1 Month Efficiency (a.k Sharpe Ratio) ...

0.14

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsAZN
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 0.65
  actual daily
 
 92 %
of total potential
 
Market Risk score

Expected Return

 0.09
  actual daily
 
 5 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.14
  actual daily
 
 7 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average AstraZeneca is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AstraZeneca by adding it to a well-diversified portfolio.
Follow AstraZeneca Performance with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add AstraZeneca to your reader
 

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium